I-Anticoagulation yinkqubo yokunciphisa ukwakheka kwe-fibrin thrombus ngokusebenzisa amayeza e-anticoagulant ukunciphisa inkqubo yendlela yangaphakathi kunye nendlela ye-intrinsic coagulation.
Iyeza lokulwa neeplatelet kukuthatha amayeza okulwa neeplatelet ukunciphisa ukunamathela kunye nomsebenzi wokuhlanganisa iiplatelet, ngaloo ndlela kunciphisa inkqubo yokwakheka kweplatelet thrombus. Kwimisebenzi yeklinikhi, amayeza okulwa neeplatelet asetyenziswa rhoqo aquka i-warfarin kunye ne-heparin, ezinciphisa amathuba okwakheka kwe-fibrinogen thrombus ngeendlela ezahlukeneyo zokulwa neeplatelet. Umzekelo, i-warfarin idla ngokusetyenziswa kunyango lokulwa neeplatelet emva kotyando lwevalvu yentliziyo, kwaye i-heparin idla ngokusetyenziswa kunyango lwe-venous thrombosis esezantsi kwemilenze.
Amayeza aqhelekileyo okulwa neeplatelet aquka i-aspirin, i-Plavix, njl. La mayeza anokuthintela ukuhlanganiswa kweeplatelet ngokusebenzisa amakhonkco ahlukeneyo, ngaloo ndlela athintele ukwakheka kwe-platelet thrombus. Ngokwezonyango, isetyenziselwa ukuthintela isifo sentliziyo, i-cerebral thrombosis kunye nezinye izifo.
I-SUCCEEDER yaseBeijing njengenye yezona mpawu ziphambili kwimarike yokuxilonga iThrombosis kunye neHemostasis eTshayina, i-SUCCEEDER inamava kumaqela e-R&D, iMveliso, iNtengiso yokuThengisa kunye neNkonzo yokubonelela nge-coagulation analyzers kunye nee-reagents, i-blood rheology analyzers, i-ESR kunye ne-HCT analyzers, i-platelet aggregation analyzers ene-ISO13485, CE Certification kunye ne-FDA ezidwelisiweyo.
Ikhadi leshishini
I-WeChat yesiTshayina